Clinical trial
SAMe to Treat Biliary Cirrhosis Symptoms
NCT00125281 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Terminated
Key facts
| NCT number | NCT00125281 |
|---|---|
| Title | SAMe to Treat Biliary Cirrhosis Symptoms |
| Official title | S-Adenosyl Methionine for Symptomatic Treatment of Primary Biliary Cirrhosis |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cirrhosis, Biliary |
| Intervention type | Drug |
| Interventions | S-adenosyl-methionine (SAMe) capsules |
| Enrollment | 50 |
| Start date | Jul 25, 2005 |
| Primary completion | Jul 31, 2007 |
| Completion | Jul 2, 2008 |
| First posted | Jul 29, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: